Zephyr AI raised $111 million in a Series A funding round led by Revolution Growth, Eli Lilly & Company, Jeff Skoll, and EPIQ Capital Group to develop fast and explainable AI solutions for precision medicine.
PRIVATEMar 13, 2024
Amount Raised
$111 Million
Round Type
Series A
McleanBiotechnologySoftwareData And AnalyticsHealth CareScience And EngineeringArtificial Intelligence
Investors
EPIQ Capital GroupJeff SkollEli Lilly & CompanyRevolution Growth
Description
Zephyr AI closed a $111 million Series A funding round with participation from Revolution Growth, Eli Lilly & Company, Jeff Skoll, and EPIQ Capital Group, among others. The funding will be used to enhance analytical speed, fortify training and validation data sets, and expand scientific and commercial teams to expedite the delivery of insights to the market.
Who to call at Zephyr AI, Inc., and when
A new round usually means Zephyr AI, Inc. is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Zephyr AI, Inc. raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Zephyr AI, Inc., from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Zephyr AI, Inc.
Location
PARKLAND HALL AT OLD PARKLAND
Mclean, Virginia, United States
About
Zephyr AI is a high-growth healthcare technology company committed to radically reshaping traditional approaches to drug discovery and precision medicine. Through partnerships and proprietary data, Zephyr AI is curating the world’s most comprehensive healthcare dataset and marrying it with cutting-edge artificial intelligence algorithms to generate novel, translatable insights to build tools and products that support both patients and providers and fuel ongoing research. At Zephyr AI, our mission-focused team of world-class software engineers and biologists leverage big data and cutting-edge technology to derive transformational insights and build enduring partnerships that will revolutionize the treatment of cancer, diabetes, and other diseases.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Zephyr AI, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
McleanBiotechnologySoftwareData And AnalyticsHealth CareScience And EngineeringArtificial Intelligence